Could the risk of asthma and atopy be reduced by a vaccine that induces a strong T-helper type 1 response?

被引:46
作者
von Hertzen, LC
Haahtela, T
机构
[1] Finnish Lung Hlth Assoc, Helsinki 00250, Finland
[2] Univ Helsinki, Cent Hosp, Skin & Allergy Hosp, Helsinki, Finland
关键词
D O I
10.1165/ajrcmb.22.2.3753
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:139 / 142
页数:4
相关论文
共 55 条
  • [51] VACIRCA A, 1994, TUBERCLE LUNG DIS, V74, P47
  • [52] A CONTROLLED FIELD TRIAL OF LIVE SALMONELLA-TYPHI STRAIN TY 21A ORAL VACCINE AGAINST TYPHOID - 3-YEAR RESULTS
    WAHDAN, MH
    SERIE, C
    CERISIER, Y
    SALLAM, S
    GERMANIER, R
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1982, 145 (03) : 292 - 295
  • [53] Wang CC, 1998, IMMUNOLOGY, V93, P307
  • [54] Interleukin-12 as a target for modulation of the inflammatory response in asthma
    Wills-Karp, M
    [J]. ALLERGY, 1998, 53 (02) : 113 - 119
  • [55] INTERLEUKIN-12 AT THE SITE OF DISEASE IN TUBERCULOSIS
    ZHANG, M
    GATELY, MK
    WANG, E
    GONG, JH
    WOLF, SF
    LU, SH
    MODLIN, RL
    BARNES, PF
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (04) : 1733 - 1739